Webcast is Live at 4:00 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jan. 21, 2014--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that it will host a live webcast of its first
quarter 2014 conference call on Thursday, January 30, at 4:00 p.m. CT
(5:00 p.m. ET). The Company will issue an earnings news release after
the market closes that afternoon.
Gary Maharaj, chief executive officer, and Andy LaFrence, vice president
of finance and chief financial officer, will recap the first quarter
2014 financial results and accomplishments. To access the webcast, go to
the investor relations portion of the Company’s website at www.surmodics.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7:00 p.m. CT on Thursday,
January 30, until 7:00 p.m. CT on Thursday, February 6, and can be
accessed by dialing 800-406-7325 and entering conference call ID
passcode 4663820. In addition, the conference call audio and transcript
will be archived on the Company’s website following the call.
About SurModics, Inc.
SurModics’ mission is to exceed our
customers’ expectations and enhance the well-being of patients by
providing the world’s foremost, innovative surface modification
technologies and in vitro diagnostic chemical components. The
Company partners with the world’s leading and emerging medical device,
diagnostic and life science companies to develop and commercialize
innovative products designed to improve patient diagnosis and treatment.
Core offerings include surface modification coating technologies that
impart lubricity, prohealing, and biocompatibility capabilities; and
components for in vitro diagnostic test kits and microarrays.
SurModics is headquartered in Eden Prairie, Minnesota. For more
information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Source: SurModics, Inc.
SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com
